Vaccination

The North Carolina Department of Health and Human Services has announced all children and adults (age 12 and up) are eligible to take the COVID-19 vaccine.

Younger teens – those between 12 and 15 – can now get the Pfizer COVID-19 vaccine. The recommendation comes following a thorough review of safety and effectiveness data from clinical trials in the United States by the Food and Drug Administration (FDA), the Advisory Committee on Immunization Practices (ACIP), and the Center for Disease Control and Prevention (CDC).

Vaccines are free to everyone. No insurance is required.

Minor Consent
A North Carolina State law changed on August 20, 2021 that now requires health care providers to obtain written consent from a parent or legal guardian of a minor prior to administration of any vaccine that that has been granted emergency use authorization and is not yet fully approved by the FDA to an individual under 18 years of age.

Once a vaccine has full FDA approval, pre-existing minor consent laws apply to consent to vaccination.

*Although minors 12-17, may receive a third additional doses if they are immunocompromised, Pfizer Booster doses are NOT approved for those that are under the age 18.

Vaccination Clinic Information

Department of Public Health
1235 Ramsey Street
Fayetteville

Monday - Friday
J&J and Pfizer
By appointment only, same day appointments available
9 a.m. – 4 p.m.

Schedule an Appointment If you need assistance scheduling your appointment, call 910- 678-7657.

Vaccination Clinic Calendar

Are you looking for a COVID-19 vaccine for a person who is at home because of limited mobility?
You may call the At-Home Vaccination Hotline at 1-866-303-0026, or fill out a registration form. For more information on at-home vaccination, visit www.ptrc.org/covid.

Have questions or concerns about getting your COVID-19 vaccine? 
NC DHHS has answers

Booster Doses and Third Doses for Immunocompromised Individuals

For individuals who received Pfizer or Moderna for their first and second dose, the CDC recommends:

For individuals who received a Pfizer-BioNTech or Moderna COVID-19 vaccine, the following groups are eligible for a booster shot at 6 months or more after their initial series:

• 65 years and older
• Age 18+ who live in long-term care settings
• Age 18+ who have underlying medical conditions
• Age 18+ who work or live in high-risk settings  

Johnson and Johnson
For individuals who received a single dose of Johnson and Johnson, the CDC recommends:

• Adults 18 or older who previously received the J&J vaccine at least two months after their first dose 

Eligible individuals may choose which vaccine they receive as a booster dose. Some people may have a preference for the vaccine type that they originally received and others, may prefer to get a different booster. CDC’s recommendations now allow for this type of mix and match dosing for booster shots.

Please note that all vaccines types may not be available at all vaccination outreach clinics. 

For individuals who are moderately to severely immunocompromised
For individuals who are moderately to severely immunocompromised and who received Pfizer or Moderna for their first and second dose, the CDC recommends:

• People who are moderately to severely immunocompromised are especially vulnerable to COVID-19 because they are more at risk of serious, prolonged illness.
  
• People who have compromised immune systems may benefit from an additional dose to make sure they have enough protection against COVID-19.
  
• CDC recommends people who are moderately to severely immunocompromised should receive an additional dose of Pfizer or Moderna after the initial 2 doses.
  

The CDC recommends third doses to:

• Cancer patients undergoing active treatment for tumors or cancers of the blood;
• Organ transplant recipients who are taking medicine to suppress their immune systems;
• Stem cell transplant recipients who are less than two years out from their transplant and taking medicine to suppress their immune systems;
• Anyone with moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome);
• Anyone with advanced or an untreated HIV infection; and
• Anyone receiving high-dose corticosteroids or other drugs that may suppress their immune response.

People should talk to their healthcare provider about their medical condition, and whether getting an additional dose is appropriate for them. Immunocompromised individuals will be asked to self-attest to their status. A note from a medical provider is not required.

A third dose needs to be given at least 28 days after a second dose and should be the same brand as the first and second dose.

Top 5 Things to Know About the Delta Variant

Monoclonal Antibodies for Treatment of COVID-19

Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like SARS-CoV-2, the virus that causes COVID-19. The Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection—in this case, the virus that causes COVID-19—and are given to patients directly with an infusion or a shot. 

If you have recently tested positive for COVID-19 and have had symptoms for 10 days or less, talk to your health care provider to see if monoclonal antibody therapy is an option for you or find a treatment center near you. Some people may qualify for preventative treatment before showing symptoms. If you have been exposed to COVID-19, talk to your health care provider for more information.

Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID-19 in certain high-risk patients.

Visit the NC DHHS website for more information.

For Health Care Providers
Allocation and distribution of REGEN-COVTM and bamlanivimab and etesevimab are currently controlled by the United States Department of Health and Human Services (US HHS). Any interested provider, who can meet the requirements of the EUA, can order product as needed directly from AmerisourceBergen using this special-order form. There is currently no cost for either REGEN-COVTM or bamlanivimab and etesevima.

Lost CDC Vaccination Card?

If you need a copy of your vaccination record, you can retrieve an electronic copy from the COVID Vaccine Management (CVMS) Recipient Portal. The electronic copy can be printed for your use from CVMS. Read the following user guide to learn how to register, check your eligibility and view your proof of vaccination after being vaccinated. 

• COVID-19 Vaccine Portal User Guide

If you are unable to access the CVMS Recipient Portal and you need a hard copy of your COVID-19 Vaccination Card, please contact our Medical Records Department at 910-433-3857.